![Mei Shirley](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mei Shirley
Directeur des opérations chez Northern Therapeutics, Inc.
Postes actifs de Mei Shirley
Sociétés | Poste | Début | Fin |
---|---|---|---|
Northern Therapeutics, Inc.
![]() Northern Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Northern Therapeutics, Inc. operate as a biotechnology company. It develops a novel method for selective gene transfer and regenerative cell therapy targeting the pulmonary vasculature with the hope of repairing damaged lung tissues in a number of respiratory and cardiopulmonary conditions, including PAH, Acute Respiratory Distress Syndrome (ARDS), Cystic Fibrosis and Emphysema. The company was founded in 2000 and is headquartered in Montréal, Canada. | Directeur des opérations | - | - |
Historique de carrière de Mei Shirley
Statistiques
Internationale
Canada | 2 |
Opérationnelle
Chief Operating Officer | 1 |
Sectorielle
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Northern Therapeutics, Inc.
![]() Northern Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Northern Therapeutics, Inc. operate as a biotechnology company. It develops a novel method for selective gene transfer and regenerative cell therapy targeting the pulmonary vasculature with the hope of repairing damaged lung tissues in a number of respiratory and cardiopulmonary conditions, including PAH, Acute Respiratory Distress Syndrome (ARDS), Cystic Fibrosis and Emphysema. The company was founded in 2000 and is headquartered in Montréal, Canada. | Commercial Services |
- Bourse
- Insiders
- Mei Shirley
- Expérience